Last reviewed · How we verify
NCT04241887
Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors
NA trial testing thoracic paravertebral blockade in Liver Tumor in 30 participants. Completed in 31 August 2019.
12 December 2018
Quick facts
| Lead sponsor | University of Warmia and Mazury |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 9 September 2017 |
| Primary completion | 12 December 2018 |
| Estimated completion | 31 August 2019 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- thoracic paravertebral blockade
- local anaesthesia — full drug profile →
Conditions studied
- Liver Tumor — all drugs for Liver Tumor →
Sponsor
University of Warmia and Mazury
Who can join
Adults 18 to 85, any sex, with Liver Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Percutaneus radiofrequency ablation (RFA) of liver tumors causes acute pain during the periooperative setting. In order to facilitate tumor access, patient should collaborate with a surgeon during the procedurę, therefore should be conscious. This study aims to assess the impact of a single shot thoracic paravertebral block (TPVB) on a patient's haemodynamic stability, patient's and operator's comfort and satisfaction during the operation and analgesia in the post-operative period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04241887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Tumor
Currently open trials in the same condition.
- NCT06594289 — Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Lapa · NA · recruiting
- NCT06524557 — Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors · recruiting
- NCT05128890 — Evaluation of Resection Techniques for Pancreatic Tumors · recruiting
Other University of Warmia and Mazury trials
Trials by the same sponsor.
- NCT04331912 — PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment · unknown
- NCT04000126 — Pupillometry - Future of Objective Pain Reaction Measurement While Unconscious · NA · completed
- NCT04194125 — Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer · Phase 2 · unknown
- NCT03771027 — Therapeutic Effect of the Low FODMAP Diet in Children With Functional Abdominal Pain. · NA · completed
- NCT03559608 — Arterial Hypertension in Men in the Warmia and Masuria Region · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04241887 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Warmia and Mazury
- Last refreshed: 27 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing